Global Mefenamic Acid Market Research Report 2024
Mefenamic acid is a member of the anthranilic acid derivatives (or fenamate) class of NSAID drugs, and is used to treat mild to moderate pain, including menstrual pain, and is sometimes used to prevent migraines associated with menstruation
According to Mr Accuracy reports’s new survey, global Mefenamic Acid market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mefenamic Acid market research.
Key manufacturers engaged in the Mefenamic Acid industry include Shionogi Pharma, Solitaire Pharmacia, Shinto Organics, Captab, EMS Pharma, Adelco, Agron Remedies, IASIS Pharmaceuticals Hellas and ABL Lifecare, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Mefenamic Acid were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Mefenamic Acid market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mefenamic Acid market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Shionogi Pharma
Solitaire Pharmacia
Shinto Organics
Captab
EMS Pharma
Adelco
Agron Remedies
IASIS Pharmaceuticals Hellas
ABL Lifecare
Farmo Quimica
Apotex
Sanofi Aventis
Yung Sine
Streuli Pharma,
Mankind
Pfizer
Daiichi Sankyo
Chemidex Pharma
AA Pharma
Nisshin Pharmaceutical
Koa Isei
Teva
Wockhardt
Esteve
Segment by Type
Patent
Generic
Segment by Application
Hospital
Drug Store
On-line
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mefenamic Acid report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Table of Content
1 Mefenamic Acid Market Overview
1.1 Product Overview and Scope of Mefenamic Acid
1.2 Mefenamic Acid Segment by Type
1.2.1 Global Mefenamic Acid Market Value Comparison by Type (2024-2034)
1.2.2 Patent
1.2.3 Generic
1.3 Mefenamic Acid Segment by Application
1.3.1 Global Mefenamic Acid Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 On-line
1.4 Global Mefenamic Acid Market Size Estimates and Forecasts
1.4.1 Global Mefenamic Acid Revenue 2018-2034
1.4.2 Global Mefenamic Acid Sales 2018-2034
1.4.3 Global Mefenamic Acid Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Mefenamic Acid Market Competition by Manufacturers
2.1 Global Mefenamic Acid Sales Market Share by Manufacturers (2018-2024)
2.2 Global Mefenamic Acid Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Mefenamic Acid Average Price by Manufacturers (2018-2024)
2.4 Global Mefenamic Acid Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mefenamic Acid, Product Type & Application
2.7 Mefenamic Acid Market Competitive Situation and Trends
2.7.1 Mefenamic Acid Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mefenamic Acid Players Market Share by Revenue
2.7.3 Global Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mefenamic Acid Retrospective Market Scenario by Region
3.1 Global Mefenamic Acid Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Mefenamic Acid Global Mefenamic Acid Sales by Region: 2018-2034
3.2.1 Global Mefenamic Acid Sales by Region: 2018-2024
3.2.2 Global Mefenamic Acid Sales by Region: 2024-2034
3.3 Global Mefenamic Acid Global Mefenamic Acid Revenue by Region: 2018-2034
3.3.1 Global Mefenamic Acid Revenue by Region: 2018-2024
3.3.2 Global Mefenamic Acid Revenue by Region: 2024-2034
3.4 North America Mefenamic Acid Market Facts & Figures by Country
3.4.1 North America Mefenamic Acid Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Mefenamic Acid Sales by Country (2018-2034)
3.4.3 North America Mefenamic Acid Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mefenamic Acid Market Facts & Figures by Country
3.5.1 Europe Mefenamic Acid Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Mefenamic Acid Sales by Country (2018-2034)
3.5.3 Europe Mefenamic Acid Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mefenamic Acid Market Facts & Figures by Country
3.6.1 Asia Pacific Mefenamic Acid Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Mefenamic Acid Sales by Country (2018-2034)
3.6.3 Asia Pacific Mefenamic Acid Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mefenamic Acid Market Facts & Figures by Country
3.7.1 Latin America Mefenamic Acid Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Mefenamic Acid Sales by Country (2018-2034)
3.7.3 Latin America Mefenamic Acid Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mefenamic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Mefenamic Acid Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Mefenamic Acid Sales by Country (2018-2034)
3.8.3 Middle East and Africa Mefenamic Acid Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mefenamic Acid Sales by Type (2018-2034)
4.1.1 Global Mefenamic Acid Sales by Type (2018-2024)
4.1.2 Global Mefenamic Acid Sales by Type (2024-2034)
4.1.3 Global Mefenamic Acid Sales Market Share by Type (2018-2034)
4.2 Global Mefenamic Acid Revenue by Type (2018-2034)
4.2.1 Global Mefenamic Acid Revenue by Type (2018-2024)
4.2.2 Global Mefenamic Acid Revenue by Type (2024-2034)
4.2.3 Global Mefenamic Acid Revenue Market Share by Type (2018-2034)
4.3 Global Mefenamic Acid Price by Type (2018-2034)
5 Segment by Application
5.1 Global Mefenamic Acid Sales by Application (2018-2034)
5.1.1 Global Mefenamic Acid Sales by Application (2018-2024)
5.1.2 Global Mefenamic Acid Sales by Application (2024-2034)
5.1.3 Global Mefenamic Acid Sales Market Share by Application (2018-2034)
5.2 Global Mefenamic Acid Revenue by Application (2018-2034)
5.2.1 Global Mefenamic Acid Revenue by Application (2018-2024)
5.2.2 Global Mefenamic Acid Revenue by Application (2024-2034)
5.2.3 Global Mefenamic Acid Revenue Market Share by Application (2018-2034)
5.3 Global Mefenamic Acid Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Shionogi Pharma
6.1.1 Shionogi Pharma Corporation Information
6.1.2 Shionogi Pharma Description and Business Overview
6.1.3 Shionogi Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Shionogi Pharma Mefenamic Acid Product Portfolio
6.1.5 Shionogi Pharma Recent Developments/Updates
6.2 Solitaire Pharmacia
6.2.1 Solitaire Pharmacia Corporation Information
6.2.2 Solitaire Pharmacia Description and Business Overview
6.2.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Solitaire Pharmacia Mefenamic Acid Product Portfolio
6.2.5 Solitaire Pharmacia Recent Developments/Updates
6.3 Shinto Organics
6.3.1 Shinto Organics Corporation Information
6.3.2 Shinto Organics Description and Business Overview
6.3.3 Shinto Organics Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Shinto Organics Mefenamic Acid Product Portfolio
6.3.5 Shinto Organics Recent Developments/Updates
6.4 Captab
6.4.1 Captab Corporation Information
6.4.2 Captab Description and Business Overview
6.4.3 Captab Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Captab Mefenamic Acid Product Portfolio
6.4.5 Captab Recent Developments/Updates
6.5 EMS Pharma
6.5.1 EMS Pharma Corporation Information
6.5.2 EMS Pharma Description and Business Overview
6.5.3 EMS Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.5.4 EMS Pharma Mefenamic Acid Product Portfolio
6.5.5 EMS Pharma Recent Developments/Updates
6.6 Adelco
6.6.1 Adelco Corporation Information
6.6.2 Adelco Description and Business Overview
6.6.3 Adelco Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Adelco Mefenamic Acid Product Portfolio
6.6.5 Adelco Recent Developments/Updates
6.7 Agron Remedies
6.6.1 Agron Remedies Corporation Information
6.6.2 Agron Remedies Description and Business Overview
6.6.3 Agron Remedies Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Agron Remedies Mefenamic Acid Product Portfolio
6.7.5 Agron Remedies Recent Developments/Updates
6.8 IASIS Pharmaceuticals Hellas
6.8.1 IASIS Pharmaceuticals Hellas Corporation Information
6.8.2 IASIS Pharmaceuticals Hellas Description and Business Overview
6.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.8.4 IASIS Pharmaceuticals Hellas Mefenamic Acid Product Portfolio
6.8.5 IASIS Pharmaceuticals Hellas Recent Developments/Updates
6.9 ABL Lifecare
6.9.1 ABL Lifecare Corporation Information
6.9.2 ABL Lifecare Description and Business Overview
6.9.3 ABL Lifecare Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.9.4 ABL Lifecare Mefenamic Acid Product Portfolio
6.9.5 ABL Lifecare Recent Developments/Updates
6.10 Farmo Quimica
6.10.1 Farmo Quimica Corporation Information
6.10.2 Farmo Quimica Description and Business Overview
6.10.3 Farmo Quimica Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Farmo Quimica Mefenamic Acid Product Portfolio
6.10.5 Farmo Quimica Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Mefenamic Acid Description and Business Overview
6.11.3 Apotex Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Apotex Mefenamic Acid Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Sanofi Aventis
6.12.1 Sanofi Aventis Corporation Information
6.12.2 Sanofi Aventis Mefenamic Acid Description and Business Overview
6.12.3 Sanofi Aventis Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Sanofi Aventis Mefenamic Acid Product Portfolio
6.12.5 Sanofi Aventis Recent Developments/Updates
6.13 Yung Sine
6.13.1 Yung Sine Corporation Information
6.13.2 Yung Sine Mefenamic Acid Description and Business Overview
6.13.3 Yung Sine Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Yung Sine Mefenamic Acid Product Portfolio
6.13.5 Yung Sine Recent Developments/Updates
6.14 Streuli Pharma,
6.14.1 Streuli Pharma, Corporation Information
6.14.2 Streuli Pharma, Mefenamic Acid Description and Business Overview
6.14.3 Streuli Pharma, Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Streuli Pharma, Mefenamic Acid Product Portfolio
6.14.5 Streuli Pharma, Recent Developments/Updates
6.15 Mankind
6.15.1 Mankind Corporation Information
6.15.2 Mankind Mefenamic Acid Description and Business Overview
6.15.3 Mankind Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Mankind Mefenamic Acid Product Portfolio
6.15.5 Mankind Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Mefenamic Acid Description and Business Overview
6.16.3 Pfizer Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Pfizer Mefenamic Acid Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Daiichi Sankyo
6.17.1 Daiichi Sankyo Corporation Information
6.17.2 Daiichi Sankyo Mefenamic Acid Description and Business Overview
6.17.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Daiichi Sankyo Mefenamic Acid Product Portfolio
6.17.5 Daiichi Sankyo Recent Developments/Updates
6.18 Chemidex Pharma
6.18.1 Chemidex Pharma Corporation Information
6.18.2 Chemidex Pharma Mefenamic Acid Description and Business Overview
6.18.3 Chemidex Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Chemidex Pharma Mefenamic Acid Product Portfolio
6.18.5 Chemidex Pharma Recent Developments/Updates
6.19 AA Pharma
6.19.1 AA Pharma Corporation Information
6.19.2 AA Pharma Mefenamic Acid Description and Business Overview
6.19.3 AA Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.19.4 AA Pharma Mefenamic Acid Product Portfolio
6.19.5 AA Pharma Recent Developments/Updates
6.20 Nisshin Pharmaceutical
6.20.1 Nisshin Pharmaceutical Corporation Information
6.20.2 Nisshin Pharmaceutical Mefenamic Acid Description and Business Overview
6.20.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Nisshin Pharmaceutical Mefenamic Acid Product Portfolio
6.20.5 Nisshin Pharmaceutical Recent Developments/Updates
6.21 Koa Isei
6.21.1 Koa Isei Corporation Information
6.21.2 Koa Isei Mefenamic Acid Description and Business Overview
6.21.3 Koa Isei Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Koa Isei Mefenamic Acid Product Portfolio
6.21.5 Koa Isei Recent Developments/Updates
6.22 Teva
6.22.1 Teva Corporation Information
6.22.2 Teva Mefenamic Acid Description and Business Overview
6.22.3 Teva Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Teva Mefenamic Acid Product Portfolio
6.22.5 Teva Recent Developments/Updates
6.23 Wockhardt
6.23.1 Wockhardt Corporation Information
6.23.2 Wockhardt Mefenamic Acid Description and Business Overview
6.23.3 Wockhardt Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Wockhardt Mefenamic Acid Product Portfolio
6.23.5 Wockhardt Recent Developments/Updates
6.24 Esteve
6.24.1 Esteve Corporation Information
6.24.2 Esteve Mefenamic Acid Description and Business Overview
6.24.3 Esteve Mefenamic Acid Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Esteve Mefenamic Acid Product Portfolio
6.24.5 Esteve Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mefenamic Acid Industry Chain Analysis
7.2 Mefenamic Acid Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mefenamic Acid Production Mode & Process
7.4 Mefenamic Acid Sales and Marketing
7.4.1 Mefenamic Acid Sales Channels
7.4.2 Mefenamic Acid Distributors
7.5 Mefenamic Acid Customers
8 Mefenamic Acid Market Dynamics
8.1 Mefenamic Acid Industry Trends
8.2 Mefenamic Acid Market Drivers
8.3 Mefenamic Acid Market Challenges
8.4 Mefenamic Acid Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Figure
List of Tables
Table 1. Global Mefenamic Acid Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Mefenamic Acid Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Mefenamic Acid Market Competitive Situation by Manufacturers in 2022
Table 4. Global Mefenamic Acid Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Mefenamic Acid Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Mefenamic Acid Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Mefenamic Acid Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Mefenamic Acid Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Mefenamic Acid, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mefenamic Acid, Product Type & Application
Table 12. Global Key Manufacturers of Mefenamic Acid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mefenamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefenamic Acid as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mefenamic Acid Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Mefenamic Acid Sales by Region (2018-2024) & (K Units)
Table 18. Global Mefenamic Acid Sales Market Share by Region (2018-2024)
Table 19. Global Mefenamic Acid Sales by Region (2024-2034) & (K Units)
Table 20. Global Mefenamic Acid Sales Market Share by Region (2024-2034)
Table 21. Global Mefenamic Acid Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Mefenamic Acid Revenue Market Share by Region (2018-2024)
Table 23. Global Mefenamic Acid Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Mefenamic Acid Revenue Market Share by Region (2024-2034)
Table 25. North America Mefenamic Acid Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Mefenamic Acid Sales by Country (2018-2024) & (K Units)
Table 27. North America Mefenamic Acid Sales by Country (2024-2034) & (K Units)
Table 28. North America Mefenamic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Mefenamic Acid Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Mefenamic Acid Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Mefenamic Acid Sales by Country (2018-2024) & (K Units)
Table 32. Europe Mefenamic Acid Sales by Country (2024-2034) & (K Units)
Table 33. Europe Mefenamic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Mefenamic Acid Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Mefenamic Acid Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Mefenamic Acid Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Mefenamic Acid Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Mefenamic Acid Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Mefenamic Acid Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Mefenamic Acid Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Mefenamic Acid Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Mefenamic Acid Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Mefenamic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Mefenamic Acid Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Mefenamic Acid Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Mefenamic Acid Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Mefenamic Acid Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Mefenamic Acid Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Mefenamic Acid Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Mefenamic Acid Sales (K Units) by Type (2018-2024)
Table 51. Global Mefenamic Acid Sales (K Units) by Type (2024-2034)
Table 52. Global Mefenamic Acid Sales Market Share by Type (2018-2024)
Table 53. Global Mefenamic Acid Sales Market Share by Type (2024-2034)
Table 54. Global Mefenamic Acid Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Mefenamic Acid Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Mefenamic Acid Revenue Market Share by Type (2018-2024)
Table 57. Global Mefenamic Acid Revenue Market Share by Type (2024-2034)
Table 58. Global Mefenamic Acid Price (US$/Unit) by Type (2018-2024)
Table 59. Global Mefenamic Acid Price (US$/Unit) by Type (2024-2034)
Table 60. Global Mefenamic Acid Sales (K Units) by Application (2018-2024)
Table 61. Global Mefenamic Acid Sales (K Units) by Application (2024-2034)
Table 62. Global Mefenamic Acid Sales Market Share by Application (2018-2024)
Table 63. Global Mefenamic Acid Sales Market Share by Application (2024-2034)
Table 64. Global Mefenamic Acid Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Mefenamic Acid Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Mefenamic Acid Revenue Market Share by Application (2018-2024)
Table 67. Global Mefenamic Acid Revenue Market Share by Application (2024-2034)
Table 68. Global Mefenamic Acid Price (US$/Unit) by Application (2018-2024)
Table 69. Global Mefenamic Acid Price (US$/Unit) by Application (2024-2034)
Table 70. Shionogi Pharma Corporation Information
Table 71. Shionogi Pharma Description and Business Overview
Table 72. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Shionogi Pharma Mefenamic Acid Product
Table 74. Shionogi Pharma Recent Developments/Updates
Table 75. Solitaire Pharmacia Corporation Information
Table 76. Solitaire Pharmacia Description and Business Overview
Table 77. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Solitaire Pharmacia Mefenamic Acid Product
Table 79. Solitaire Pharmacia Recent Developments/Updates
Table 80. Shinto Organics Corporation Information
Table 81. Shinto Organics Description and Business Overview
Table 82. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Shinto Organics Mefenamic Acid Product
Table 84. Shinto Organics Recent Developments/Updates
Table 85. Captab Corporation Information
Table 86. Captab Description and Business Overview
Table 87. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Captab Mefenamic Acid Product
Table 89. Captab Recent Developments/Updates
Table 90. EMS Pharma Corporation Information
Table 91. EMS Pharma Description and Business Overview
Table 92. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. EMS Pharma Mefenamic Acid Product
Table 94. EMS Pharma Recent Developments/Updates
Table 95. Adelco Corporation Information
Table 96. Adelco Description and Business Overview
Table 97. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Adelco Mefenamic Acid Product
Table 99. Adelco Recent Developments/Updates
Table 100. Agron Remedies Corporation Information
Table 101. Agron Remedies Description and Business Overview
Table 102. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Agron Remedies Mefenamic Acid Product
Table 104. Agron Remedies Recent Developments/Updates
Table 105. IASIS Pharmaceuticals Hellas Corporation Information
Table 106. IASIS Pharmaceuticals Hellas Description and Business Overview
Table 107. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. IASIS Pharmaceuticals Hellas Mefenamic Acid Product
Table 109. IASIS Pharmaceuticals Hellas Recent Developments/Updates
Table 110. ABL Lifecare Corporation Information
Table 111. ABL Lifecare Description and Business Overview
Table 112. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. ABL Lifecare Mefenamic Acid Product
Table 114. ABL Lifecare Recent Developments/Updates
Table 115. Farmo Quimica Corporation Information
Table 116. Farmo Quimica Description and Business Overview
Table 117. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Farmo Quimica Mefenamic Acid Product
Table 119. Farmo Quimica Recent Developments/Updates
Table 120. Apotex Corporation Information
Table 121. Apotex Description and Business Overview
Table 122. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Apotex Mefenamic Acid Product
Table 124. Apotex Recent Developments/Updates
Table 125. Sanofi Aventis Corporation Information
Table 126. Sanofi Aventis Description and Business Overview
Table 127. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Sanofi Aventis Mefenamic Acid Product
Table 129. Sanofi Aventis Recent Developments/Updates
Table 130. Yung Sine Corporation Information
Table 131. Yung Sine Description and Business Overview
Table 132. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Yung Sine Mefenamic Acid Product
Table 134. Yung Sine Recent Developments/Updates
Table 135. Streuli Pharma, Corporation Information
Table 136. Streuli Pharma, Description and Business Overview
Table 137. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Streuli Pharma, Mefenamic Acid Product
Table 139. Streuli Pharma, Recent Developments/Updates
Table 140. Mankind Corporation Information
Table 141. Mankind Description and Business Overview
Table 142. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Mankind Mefenamic Acid Product
Table 144. Mankind Recent Developments/Updates
Table 145. Pfizer Corporation Information
Table 146. Pfizer Description and Business Overview
Table 147. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Pfizer Mefenamic Acid Product
Table 149. Pfizer Recent Developments/Updates
Table 150. Daiichi Sankyo Corporation Information
Table 151. Daiichi Sankyo Description and Business Overview
Table 152. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Daiichi Sankyo Mefenamic Acid Product
Table 154. Daiichi Sankyo Recent Developments/Updates
Table 155. Chemidex Pharma Corporation Information
Table 156. Chemidex Pharma Description and Business Overview
Table 157. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Chemidex Pharma Mefenamic Acid Product
Table 159. Chemidex Pharma Recent Developments/Updates
Table 160. AA Pharma Corporation Information
Table 161. AA Pharma Description and Business Overview
Table 162. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. AA Pharma Mefenamic Acid Product
Table 164. AA Pharma Recent Developments/Updates
Table 165. Nisshin Pharmaceutical Corporation Information
Table 166. Nisshin Pharmaceutical Description and Business Overview
Table 167. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Nisshin Pharmaceutical Mefenamic Acid Product
Table 169. Nisshin Pharmaceutical Recent Developments/Updates
Table 170. Koa Isei Corporation Information
Table 171. Koa Isei Description and Business Overview
Table 172. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Koa Isei Mefenamic Acid Product
Table 174. Koa Isei Recent Developments/Updates
Table 175. Teva Corporation Information
Table 176. Teva Description and Business Overview
Table 177. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Teva Mefenamic Acid Product
Table 179. Teva Recent Developments/Updates
Table 180. Wockhardt Corporation Information
Table 181. Wockhardt Description and Business Overview
Table 182. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Wockhardt Mefenamic Acid Product
Table 184. Wockhardt Recent Developments/Updates
Table 185. Esteve Corporation Information
Table 186. Esteve Description and Business Overview
Table 187. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Esteve Mefenamic Acid Product
Table 189. Esteve Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Mefenamic Acid Distributors List
Table 193. Mefenamic Acid Customers List
Table 194. Mefenamic Acid Market Trends
Table 195. Mefenamic Acid Market Drivers
Table 196. Mefenamic Acid Market Challenges
Table 197. Mefenamic Acid Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mefenamic Acid
Figure 2. Global Mefenamic Acid Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Mefenamic Acid Market Share by Type in 2022 & 2034
Figure 4. Patent Product Picture
Figure 5. Generic Product Picture
Figure 6. Global Mefenamic Acid Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Mefenamic Acid Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. On-line
Figure 11. Global Mefenamic Acid Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Mefenamic Acid Market Size (2018-2034) & (US$ Million)
Figure 13. Global Mefenamic Acid Sales (2018-2034) & (K Units)
Figure 14. Global Mefenamic Acid Average Price (US$/Unit) & (2018-2034)
Figure 15. Mefenamic Acid Report Years Considered
Figure 16. Mefenamic Acid Sales Share by Manufacturers in 2022
Figure 17. Global Mefenamic Acid Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Mefenamic Acid Players: Market Share by Revenue in 2022
Figure 19. Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Mefenamic Acid Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Mefenamic Acid Sales Market Share by Country (2018-2034)
Figure 22. North America Mefenamic Acid Revenue Market Share by Country (2018-2034)
Figure 23. United States Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Mefenamic Acid Sales Market Share by Country (2018-2034)
Figure 26. Europe Mefenamic Acid Revenue Market Share by Country (2018-2034)
Figure 27. Germany Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Mefenamic Acid Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Mefenamic Acid Revenue Market Share by Region (2018-2034)
Figure 34. China Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Mefenamic Acid Sales Market Share by Country (2018-2034)
Figure 44. Latin America Mefenamic Acid Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Mefenamic Acid Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Mefenamic Acid Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Mefenamic Acid Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Mefenamic Acid by Type (2018-2034)
Figure 54. Global Revenue Market Share of Mefenamic Acid by Type (2018-2034)
Figure 55. Global Mefenamic Acid Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Mefenamic Acid by Application (2018-2034)
Figure 57. Global Revenue Market Share of Mefenamic Acid by Application (2018-2034)
Figure 58. Global Mefenamic Acid Price (US$/Unit) by Application (2018-2034)
Figure 59. Mefenamic Acid Value Chain
Figure 60. Mefenamic Acid Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed